Metraipolis › archive › dc_eb6f2d55983e

Sodium-Glucose Cotransporter-2 Inhibitors in Diabetes and Beyond: Mechanisms, Pleiotropic Benefits, and Clinical Use-Reviewing Protective Effects Exceeding… — Europe PMC PMID:41157142

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41157142
DOI
10.3390/molecules30204125
License (as archived)
solo-consultazione
Archived
2026-11-09T05:20:19.648Z
SHA-256 of the archived text
e676ae8323576391ebcce10b4f0cff102a9f6f6d636ec5b6504513d8b3d74c74
Stable URL of this page
https://metraipolis.com/documento/dc_eb6f2d55983e

How to cite

Sodium-Glucose Cotransporter-2 Inhibitors in Diabetes and Beyond: Mechanisms, Pleiotropic Benefits, and Clinical Use-Reviewing Protective Effects Exceeding… — Europe PMC PMID:41157142 — Europe PMC (en), https://europepmc.org/article/MED/41157142 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eb6f2d55983e (Metraipolis archive dc_eb6f2d55983e, sha256 e676ae8323576391ebcce10b4f0cff102a9f6f6d636ec5b6504513d8b3d74c74)
BibTeX
@misc{dceb6f2d55983e,
  title = {Sodium-Glucose Cotransporter-2 Inhibitors in Diabetes and Beyond: Mechanisms, Pleiotropic Benefits, and Clinical Use-Reviewing Protective Effects Exceeding… — Europe PMC PMID:41157142},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41157142},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eb6f2d55983e; sha256 e676ae8323576391ebcce10b4f0cff102a9f6f6d636ec5b6504513d8b3d74c74},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41157142. Agents can read the archived copy with the MCP tool read_document.